Rethinking medulloblastoma from a targeted therapeutics perspective.
Yuuri HashimotoMarta Penas-PradoShouhao ZhouJun WeiSoumen KhatuaTiffany R HodgesNader SanaiJoanne XiuZoran GatalicaLyndon KimSantosh KesariGanesh RaoDavid SpetzlerAmy B HeimbergerPublished in: Journal of neuro-oncology (2018)
Therapeutics are available for several of the frequently expressed targets, providing a justification for their consideration in the setting of medulloblastoma.